6838 — Formosa Pharmaceuticals Cashflow Statement
0.000.00%
- TWD4.00bn
- TWD2.59bn
- TWD9.50m
Annual cashflow statement for Formosa Pharmaceuticals, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -398 | -402 | -300 | -180 | -84 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 39.4 | 3.1 | 28.8 | 30.4 | -24.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -9.87 | 13.6 | 34.7 | -21.8 | -36.7 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -331 | -346 | -196 | -129 | -95.6 |
| Capital Expenditures | -15.1 | 0 | -2.25 | -8.25 | -41.9 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -71 | -189 | -674 | -467 | -26.4 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -86.1 | -189 | -676 | -475 | -68.3 |
| Financing Cash Flow Items | — | 58.4 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 605 | 559 | 1,000 | 624 | -6.13 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 167 | 58.4 | 117 | 41.1 | -184 |